Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma
From the Danish “MALOVA” ovarian carcinoma study
Version of Record online: 26 APR 2004
Copyright © 2004 American Cancer Society
Volume 100, Issue 11, pages 2387–2395, 1 June 2004
How to Cite
Høgdall, E. V. S., Ryan, A., Kjaer, S. K., Blaakaer, J., Christensen, L., Bock, J. E., Glud, E., Jacobs, I. J. and Høgdall, C. K. (2004), Loss of heterozygosity on the X chromosome is an independent prognostic factor in ovarian carcinoma. Cancer, 100: 2387–2395. doi: 10.1002/cncr.20213
- Issue online: 18 MAY 2004
- Version of Record online: 26 APR 2004
- Manuscript Accepted: 19 FEB 2004
- Manuscript Revised: 5 FEB 2004
- Manuscript Received: 28 JUL 2003
- Det Obelske Familiefond
- Erik Hørslev og hustru Birgit Hørslevs Fond
- Arvid Nielsson's Fond
- Overlæge Johan Boserup og Lise Boserups Legat
- Apotekerfonden af 1991
- Hans og Nora Buchards Fond
- Grosserer M. Brogaard og Hustrus Mindefond
- The Danish Cancer Society
- National Cancer Institute. Grant Number: RO1 CA 61107
- loss of heterozygosity (LOH);
- ovarian carcinoma (OC);
- microsatellite markers;
- prognostic factors
Ovarian carcinoma (OC) is the fifth most frequent female cancer type and the fourth most frequent cause of death from cancer among women in Denmark. At the time they are diagnosed with OC, approximately 70% of patients have advanced disease. It is believed that loss of tumor suppressor gene activity plays an important role in the origin and progression of OC and other malignancies. Loss of heterozygosity (LOH) may be detected in individuals heterozygous for an allele and is associated with loss of function of tumor suppressor genes.
The polymorphic marker regions (TP53, CACNLB1, D18S58, DXS538, and DXS454) were amplified by polymerase chain reaction followed by separation using gel electrophoresis before LOH was identified. In total, 160 women with primary epithelial OC were included in the study.
Univariate analyses showed significant differences in survival between patients who had advanced OC with LOH or with retention using the microsatellite markers DXS454 (P = 0.04) and DXS538 (P = 0.01). Multivariate Cox regression analysis that included all patients showed that DXS454 (relative hazard [RH] = 3.5; P = 0.002; 95% confidence interval [95% CI], 1.6–7.8), radicality of primary surgery (RH = 5.5; P < 0.0001; 95% CI, 2.7–11.1), and serum tetranectin level (RH = 0.8; P = 0.009; 95% CI, 0.7–0.9) were independent prognostic factors for survival. Multivariate Cox regression analysis restricted to patients with International Federation of Obstetrics and Gynecology Stage III–IV disease showed that DXS454 (RH = 3.4; P = 0.007; 95% CI, 1.4–8.1), radicality of primary surgery (RH = 5.4; P < 0.0001; 95% CI, 2.2–12.9), and serum tetranectin level (RH = 0.8; P = 0.042; 95% CI, 0.7–1.0) were independent prognostic factors.
LOH at DXS454 (Xq21-q23) appeared to be correlated with reduced survival in patients with OC. Cancer 2004. © 2004 American Cancer Society.